Martel Catherine
Faculty of Medicine, Université de Montréal, Montreal Heart Institute, 5000, Belanger Street, Montreal, Quebec, H1T 1C8, Canada.
Future Sci OA. 2016 Feb 12;2(1):FSO108. doi: 10.4155/fsoa-2016-0011. eCollection 2016 Mar.
Catherine Martel obtained her PhD from the Université de Montréal and pursued a postdoctoral fellowship first at Mount Sinai School of Medicine in New York (NY, USA), then at Washington University School of Medicine in St Louis (MO, USA), and obtained the Junior Investigator Award for Women from the Arteriosclerosis, Thrombosis and Vascular Biology council of the American Heart Association. Her postdoctoral work is certainly groundbreaking and brings forward new considerations in the field: she discovered that the lymphatic vessel route, the network that runs in parallel with the blood vessels, is critical for removing cholesterol from multiple tissues, including the aortic wall. In 2013, she joined the Arteriosclerosis, Thrombosis and Vascular Biology Early Career Committee, eager to bring a Canadian perspective to the group and get involved in council activities. Since 2014, she is an Assistant Professor at the Department of Medicine at the Université de Montréal, and a research scientist at the Montreal Heart Institute. Her research program now focuses on characterizing the physiopathologic role of the lymphatics in the initiation, progression and regression of atherosclerosis. Basic and translational research will allow her team to identify the causes of lymphatic dysfunction, and eventually target potential therapeutic strategies aiming at improving lymphatic function at the different levels of the atherothrombotic disease. You can follow her laboratory at @LaboMartel_ICM.
凯瑟琳·马特尔在蒙特利尔大学获得博士学位，随后先在美国纽约西奈山医学院、后在美国密苏里州圣路易斯华盛顿大学医学院从事博士后研究工作，并获得了美国心脏协会动脉硬化、血栓形成与血管生物学委员会颁发的女性青年研究者奖。她的博士后工作无疑具有开创性，并为该领域带来了新的思考：她发现与血管并行的淋巴管网络对于从包括主动脉壁在内的多个组织中清除胆固醇至关重要。2013年，她加入了动脉硬化、血栓形成与血管生物学早期职业委员会，渴望为该团体带来加拿大视角并参与委员会活动。自2014年起，她担任蒙特利尔大学医学系助理教授以及蒙特利尔心脏研究所的研究科学家。她目前的研究项目专注于阐明淋巴管在动脉粥样硬化的发生、发展和消退过程中的病理生理作用。基础研究和转化研究将使她的团队能够确定淋巴管功能障碍的原因，并最终针对旨在改善动脉粥样硬化血栓形成疾病不同阶段淋巴管功能的潜在治疗策略。你可以通过@LaboMartel_ICM关注她的实验室。
